1.
Dimachkie MM, Hanna M, Machado P, Herbelin L, Pasnoor M, Jawdat O, et al. Phase II Study of Arimoclomol in IBM FDA-OOPD . rrnmf [Internet]. 2021 Aug. 3 [cited 2024 Nov. 24];2(3):104-42. Available from: https://journals.ku.edu/rrnmf/article/view/15728